Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $82.2M
Liabilities Breakdown FY2016
Total Liabilities: $92.2M
Asset Breakdown
Total Assets: $82.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $63.3M | 76.9% |
| Accounts Receivable | $693.0K | 0.8% |
| Inventory | $5.2M | 6.4% |
| Property, Plant & Equipment | $8.7M | 10.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.3M | 5.3% |
Liabilities Breakdown
Total Liabilities: $92.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.5M | 8.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $84.7M | 91.9% |